Pharmaceutical Business review

Cynosure wins Korean approval to market Accolade

Accolade is a high-powered 755nm, Q-switched Alexandrite laser for the removal of pigmented lesions. The unique combination of various spot sizes and the laser’s high repetition rates is said to allow for rapid treatment.

Introduced in the first quarter of 2008, the Accolade is the third Cynosure flagship product approved for marketing in South Korea, following the Elite Aesthetic Workstation for laser hair removal and the Cynergy Workstation with MultiPlex Technology for the treatment of dermatological vascular conditions. All three workstations are being distributed in South Korea through Seoul-based OrientMG.

Michael Davin, president and CEO of Cynosure, said: “Due to the prevalence of dermal melanoses among Asian populations, South Korea is a primary target market for Accolade. We also are pursuing regulatory approval in other Asia Pacific countries, including China.”